Advertisement

Topics

SanBio's US-based Phase 1/2a Clinical Trial of SB623 for the Treatment of Chronic Motor Deficit from Ischemic Stroke Was Addressed at an Event Held by California Institute for Regenerative Medicine (CIRM)

22:30 EDT 14 Jun 2018 | Businesswire

SanBio Co., Ltd.

The SanBio Group (SanBio Co., Ltd. and subsidiary SanBio, Inc.), a scientific leader in regenerative medicine for neurological disorders, hereby announces that the US-based phase 1/2a clinical trial of SB623 for the treatment of chronic motor deficit from ischemic stroke conducted by the SanBio group was addressed at an event held by California Institute for Regenerative Medicine (CIRM) on May 31, 2018.

The recording of the event is available for view at https://www.facebook.com/CaliforniaInstituteForRegenerativeMedicine/

SanBio, Inc. and SanBio Co., Ltd.

SanBio group is engaged in the regenerative medicine business spanning research, development, manufacture, and sales of regenerative medicines. In regards to its propriety regenerative medicine product SB623, SanBio is conducting a phase 2b clinical trial for the treatment of chronic motor deficit from ischemic stroke in the US together with its development partner in the US and Canada, Sumitomo Dainippon Pharma Co., Ltd. On its own, SanBio is conducting a global phase 2 clinical trial of SB623 targeting chronic motor deficit from TBI in Japan and the US. Headquartered in Tokyo, SanBio has its main R&D base in Mountain View, California in the US.

For more information, contact:
SanBio Co., Ltd.
Masahito Kumagae, +81-3-6264-3481
Management Administration

NEXT ARTICLE

More From BioPortfolio on "SanBio's US-based Phase 1/2a Clinical Trial of SB623 for the Treatment of Chronic Motor Deficit from Ischemic Stroke Was Addressed at an Event Held by California Institute for Regenerative Medicine (CIRM)"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...